中文
About Us
GV-971
Scientific Research Information
News
Social Responsibility
Careers
Contact Us
CN
Press Releases

Press Releases
Press Releases
News Reports
Press Releases
News Reports
Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression
Date：2019-10-31

image.pngimage.png

image.png

image.png

image.png

image.png

image.png

image.png

image.png

image.png

image.pngimage.png

image.png

image.png

image.png

image.png

image.png

image.png

image.png


ShareTo：
Previous Page：
Green Valley Announces NMPA Approval Of Oligomannate For Mild To Moderate Alzheimer's Disease
Next Page：
Prof. Sangram Sisodia's Academic Visit to Green Valley Pharmaceuticals